▁British 8.626843452453613
▁Bi 8.045165061950684
ote 1.8138569593429565
ch 0.12307431548833847
’ 4.396496772766113
s 0.007620568387210369
▁Mar 8.188370704650879
im 7.856335163116455
ast 0.8561438322067261
at 0.0003489864757284522
▁anti 8.74013614654541
- 0.05171859636902809
can 1.464468002319336
cer 0.0009111739927902818
▁treatment 3.075822353363037
▁will 4.732245445251465
▁be 0.7497433423995972
▁review 4.993326663970947
ed 0.002337085083127022
▁at 3.8938446044921875
▁the 1.1229130029678345
▁up 3.2162129878997803
coming 0.010990655049681664
▁European 2.6845297813415527
▁Society 2.190541982650757
▁for 0.4507213830947876
▁Medical 0.07668313384056091
▁On 0.003309953259304166
col 0.00260859914124012
ogy 5.972563667455688e-05
▁( 0.29072120785713196
ES 0.006770771462470293
MO 0.00010908245167229325
) 0.034393686801195145
▁conference 2.1448099613189697
▁in 0.9521828889846802
▁Vienna 2.7173237800598145
. 1.1449153423309326
▁The 1.7995364665985107
▁top 8.58204174041748
ical 2.453418731689453
▁gel 1.8381134271621704
- 4.209147930145264
based 0.383661687374115
▁treatment 1.018318772315979
, 2.2655694484710693
▁originally 5.008307456970215
▁developed 0.3917091190814972
▁to 2.954632043838501
▁treat 0.47516292333602905
▁breast 5.900075435638428
▁cancer 0.13663025200366974
, 0.20886969566345215
▁has 1.3925211429595947
▁shown 1.7236212491989136
▁prom 2.0046582221984863
ising 0.0030508041381835938
▁results 0.29410266876220703
▁in 0.33059147000312805
▁clin 3.1297030448913574
ical 0.0020743650384247303
▁tri 0.15288516879081726
als 9.871016663964838e-05
. 2.763709783554077
<0x0A> 0.6927125453948975
Mar 1.1763930320739746
im 0.014209069311618805
ast 0.0006130428519099951
at 0.0003463629400357604
▁is 0.769987165927887
▁a 0.9539135098457336
▁matrix 3.864729166030884
▁metal 0.028604675084352493
lo 0.0012797554954886436
prote 0.06829094886779785
in 0.06354980170726776
ase 0.01816246099770069
▁in 1.1987195014953613
hib 0.0004380112513899803
itor 0.004745280370116234
, 1.2873796224594116
▁which 0.9285264611244202
▁means 2.394779682159424
▁it 0.3423003852367401
▁targets 3.2362914085388184
▁en 2.2018914222717285
zym 0.00012613138824235648
es 0.013976577669382095
▁that 0.5518912076950073
▁play 2.8026366233825684
▁a 0.2943730354309082
▁role 0.7390040755271912
▁in 0.004851947072893381
▁the 1.2653164863586426
▁growth 1.5444785356521606
▁and 0.6254211068153381
▁spread 0.1784578114748001
▁of 0.020499294623732567
▁cancer 0.3450339138507843
▁cells 0.7645559310913086
. 0.13506846129894257
▁In 2.486321210861206
▁pre 3.184696674346924
cl 0.6880937218666077
in 6.914378172950819e-05
ical 0.0013091188156977296
▁studies 0.8283804655075073
, 0.2108621746301651
▁it 1.7040892839431763
▁was 1.5802582502365112
▁shown 0.9497109651565552
▁to 0.08253052085638046
▁in 1.841064691543579
hib 0.007733788341283798
it 0.00045679512550123036
▁the 0.8518707752227783
▁growth 0.45165175199508667
▁of 0.16804370284080505
▁tum 1.7445895671844482
ors 1.748730182647705
▁and 1.6594886779785156
▁reduce 2.0021657943725586
▁the 1.1360735893249512
▁ch 5.945491790771484
ances 0.014662242494523525
▁of 0.048018038272857666
▁met 1.3073328733444214
ast 0.0011507931631058455
asis 0.11460404098033905
. 0.48645132780075073
<0x0A> 0.3563878834247589
The 1.2422120571136475
▁gel 2.4365785121917725
- 1.7053720951080322
based 0.03780164569616318
▁form 1.1834074258804321
ulation 0.09513117372989655
▁allows 2.9257166385650635
▁the 1.678306221961975
▁drug 0.7878069281578064
▁to 0.0034184406977146864
▁be 0.3308604657649994
▁applied 1.0028622150421143
▁top 2.6392650604248047
ically 0.0011627876665443182
▁to 0.9336687922477722
▁the 0.2482593059539795
▁breast 3.3336904048919678
▁area 2.801424503326416
, 0.49968940019607544
▁which 1.436861276626587
▁could 1.9230507612228394
▁reduce 1.9334055185317993
▁the 0.505539059638977
▁side 1.250948429107666
▁effects 0.02843412011861801
▁associated 0.8623786568641663
▁with 0.00017578955157659948
▁traditional 1.62184476852417
▁chem 1.617266058921814
other 0.00304673844948411
apy 0.024772625416517258
▁treat 0.7191946506500244
ments 2.4080563889583573e-05
. 0.08406300097703934
▁The 2.186737060546875
▁treatment 1.428056001663208
▁is 0.6623300909996033
▁applied 3.669532299041748
▁using 3.945798873901367
▁a 0.2597756087779999
▁patch 3.9297194480895996
, 1.2217848300933838
▁applied 6.415327072143555
▁to 1.5374356508255005
▁the 0.059435103088617325
▁breast 1.2414664030075073
▁area 0.905426561832428
▁daily 3.3335142135620117
▁for 0.21888744831085205
▁two 1.9634374380111694
▁weeks 0.11276014894247055
▁prior 6.442795276641846
▁to 0.005036020185798407
▁surg 0.33204159140586853
ery 0.01740318536758423
. 0.6451653838157654
<0x0A> 0.3907698690891266
The 1.1394336223602295
▁phase 3.2307047843933105
▁II 1.339685082435608
▁clin 1.1289530992507935
ical 0.0003606731479521841
▁trial 0.303875595331192
▁conducted 4.043579578399658
▁on 2.581932783126831
▁ 0.8895274996757507
2 1.8253685235977173
0 1.7070560455322266
9 3.79351544380188
▁women 1.5052720308303833
▁with 0.6507635116577148
▁breast 1.2944015264511108
▁cancer 0.015018743462860584
▁showed 1.0519040822982788
▁a 2.3578925132751465
▁significant 1.5962282419204712
▁improvement 1.1884212493896484
▁in 0.022437620908021927
▁disease 2.7034964561462402
- 0.11089055985212326
free 0.004082657862454653
▁surv 0.03315484896302223
ival 0.00047325363266281784
▁and 1.7177664041519165
▁overall 0.6445226073265076
▁surv 0.010369593277573586
ival 0.00017084150749724358
▁rates 1.3155156373977661
. 1.1980971097946167
▁After 4.931972026824951
▁three 2.503324270248413
▁years 0.045212581753730774
, 0.5233972072601318
▁the 0.7857033014297485
▁patients 4.7851362228393555
▁who 0.9945580959320068
▁received 0.37165457010269165
▁Mar 0.6007228493690491
im 0.004832122009247541
ast 0.0005286541418172419
at 0.0007338235736824572
▁had 0.3021499514579773
▁a 0.11044154316186905
▁ 0.2847689390182495
3 2.051854133605957
5 2.3090717792510986
% 0.20364446938037872
▁reduction 1.2936911582946777
▁in 0.0022321799769997597
▁the 0.4356151819229126
▁risk 0.08736702799797058
▁of 0.0011007882421836257
▁disease 2.1006178855895996
▁rec 0.4826187491416931
urrence 0.00687519321218133
▁compared 1.1882517337799072
▁to 0.03387364745140076
▁the 1.5288879871368408
▁place 1.2218009233474731
bo 0.00017996261885855347
▁group 0.016330963000655174
. 0.08563815802335739
<0x0A> 0.39746689796447754
The 0.9335331320762634
▁treatment 2.1517529487609863
▁also 2.4927780628204346
▁showed 0.6186769008636475
▁promise 2.216848373413086
▁in 0.09801982343196869
▁delay 5.8888163566589355
ing 0.00015629558765795082
▁the 0.18539531528949738
▁pro 1.537198781967163
gression 0.0012807700550183654
▁of 0.0068294028751552105
▁triple 3.724655866622925
- 0.21534354984760284
negative 0.00135077815502882
▁breast 0.022919846698641777
▁cancer 0.008945722132921219
, 0.5136512517929077
▁a 0.7053608298301697
▁particularly 1.520193099975586
▁ag 0.026435859501361847
gress 2.3484506527893245e-05
ive 7.033372639853042e-06
▁form 0.24990800023078918
▁of 0.0023304533679038286
▁the 0.06106916442513466
▁disease 0.002586010145023465
▁with 3.8975589275360107
▁limited 1.0142292976379395
▁treatment 0.01565626449882984
▁options 0.00018246646504849195
. 0.024616405367851257
▁The 1.9148236513137817
▁results 2.0927064418792725
▁of 0.375529021024704
▁the 0.6763477921485901
▁clin 2.170008659362793
ical 0.00024971505627036095
▁trial 0.1180635541677475
▁were 1.0523139238357544
▁published 0.5762993097305298
▁in 0.013500940054655075
▁the 0.13619016110897064
▁Lanc 3.133601188659668
et 3.194859891664237e-05
▁On 0.23576584458351135
col 3.7432415410876274e-05
ogy 0.00024208376999013126
▁journal 0.33185064792633057
▁earlier 4.562015533447266
▁this 0.01214114110916853
▁year 0.041591960936784744
. 0.18305304646492004
<0x0A> 0.020912963896989822
Pro 6.355519771575928
f 0.1771727204322815
essor 0.12834107875823975
▁Jud 5.385509490966797
ith 0.19921256601810455
▁Bl 0.011874084360897541
iss 0.0016858475282788277
▁of 3.314472198486328
▁the 0.39310604333877563
▁Institute 1.992674708366394
▁of 0.031174564734101295
▁Can 0.04871293529868126
cer 8.046950824791566e-05
▁Research 0.02741304785013199
, 0.9315627217292786
▁one 2.7770795822143555
▁of 0.0004316903941798955
▁the 0.013134289532899857
▁lead 1.5981545448303223
▁investig 1.1688120365142822
ators 0.0009754883940331638
▁of 0.5676196813583374
▁the 0.002183196134865284
▁clin 1.1690177917480469
ical 0.0002676010481081903
▁trial 0.1037832573056221
, 0.02832319214940071
▁commented 2.882655382156372
: 2.3719513416290283
▁" 3.205003261566162
The 2.0448358058929443
▁results 0.9838316440582275
▁of 0.5681170225143433
▁this 0.6666419506072998
▁clin 2.5848331451416016
ical 0.0004207184538245201
▁trial 0.04514667019248009
▁demonstrate 3.2326300144195557
▁the 1.4162795543670654
▁potential 0.23251064121723175
▁of 0.28147971630096436
▁Mar 1.0212491750717163
im 0.007607654668390751
ast 0.0003618656483013183
at 0.0005392693565227091
▁to 0.6217547655105591
▁improve 1.5682767629623413
▁surv 2.2564103603363037
ival 0.00048243714263662696
▁rates 1.9404057264328003
▁for 0.934176504611969
▁women 0.5631842613220215
▁with 0.06975822150707245
▁breast 0.9928970336914062
▁cancer 0.002117788651958108
. 0.877411961555481
▁It 2.8556411266326904
’ 4.479172229766846
s 0.0002066706510959193
▁exc 2.124305486679077
iting 0.0001326887431787327
▁to 0.44206663966178894
▁see 0.36705681681632996
▁a 1.894099235534668
▁novel 3.1456189155578613
▁treatment 0.9796494245529175
▁like 2.303415298461914
▁Mar 1.2136327028274536
im 0.0008874896448105574
ast 9.203380614053458e-05
at 0.0002493573119863868
▁showing 2.72369647026062
▁such 0.7928874492645264
▁prom 0.8371595144271851
ising 0.00015009575872682035
▁results 0.09602723270654678
." 2.4563000202178955
<0x0A> 0.02076130174100399
The 1.0804656744003296
▁ES 2.7833001613616943
MO 6.222917727427557e-05
▁conference 0.069776251912117
, 1.6714112758636475
▁which 0.6134554147720337
▁is 1.7624342441558838
▁being 2.193399667739868
▁held 0.03330501168966293
▁from 0.6526239514350891
▁ 1.692384958267212
2 1.3251726627349854
5 2.716655969619751
th 1.3549941778182983
▁September 2.3641698360443115
▁to 0.097647525370121
▁ 0.037585265934467316
2 0.749830961227417
9 0.3793600797653198
th 0.0008348133997060359
▁September 0.04535234346985817
, 0.3256261944770813
▁brings 3.5275604724884033
▁together 0.0024777925573289394
▁leading 1.4990416765213013
▁on 0.851192831993103
colog 1.0384689569473267
ists 0.0004602537374012172
▁and 0.9261819124221802
▁medical 3.029054641723633
▁profession 0.7605971693992615
als 1.5139694369281642e-05
▁to 2.050342559814453
▁discuss 0.6193593740463257
▁the 0.2715061604976654
▁latest 0.0015521168243139982
▁develop 0.7402360439300537
ments 1.025205165205989e-05
▁in 0.08604694157838821
▁cancer 0.40695005655288696
▁treat 3.466068983078003
ments 4.1485694964649156e-05
▁and 1.0192269086837769
▁research 0.19169466197490692
. 0.005387427750974894
<0x0A> 1.1533658504486084
The 1.2675827741622925
▁review 4.987835884094238
▁of 0.08995682746171951
▁Mar 0.1501697152853012
im 0.0032062616664916277
ast 0.00043383712181821465
at 0.0004341948661021888
▁is 1.3012744188308716
▁expected 1.8532377481460571
▁to 0.0004357452562544495
▁generate 0.9258679747581482
▁significant 0.3920125961303711
▁interest 0.017023280262947083
▁among 0.8102883100509644
▁the 0.8853444457054138
▁health 7.633941650390625
care 0.037655264139175415
▁community 0.39941394329071045
, 0.4392804503440857
▁with 2.2291946411132812
▁the 0.7768943905830383
▁potential 0.30500170588493347
▁to 0.5435842871665955
▁open 5.328865051269531
▁up 0.18063858151435852
▁a 1.3188709020614624
▁new 0.02117970772087574
▁a 1.1659961938858032
venue 0.001168516231700778
▁of 1.4012080430984497
▁treatment 0.11223327368497849
▁for 0.021242355927824974
▁breast 0.6878985166549683
▁cancer 0.003657823894172907
▁patients 0.13708195090293884
. 0.08484089374542236
<0x0A> 0.5288585424423218
" 4.354459762573242
Mar 3.077716588973999
im 0.005059742834419012
ast 0.00013459633919410408
at 0.00033121826709248126
▁has 1.2000917196273804
▁the 0.6144064664840698
▁potential 0.004542879294604063
▁to 0.00037617605994455516
▁make 3.4922683238983154
▁a 0.054544154554605484
▁real 0.9940260648727417
▁difference 0.03779694065451622
▁to 1.6215641498565674
▁the 0.35968106985092163
▁lives 0.07479365170001984
▁of 0.0006745943683199584
▁millions 5.162036895751953
▁of 0.001747763715684414
▁women 0.6160109639167786
▁around 1.9175055027008057
▁the 0.00039495876990258694
▁world 0.0103309890255332
▁who 0.6721754670143127
▁are 0.056943509727716446
▁living 1.8700048923492432
▁with 0.0005791672156192362
▁breast 0.18379093706607819
▁cancer 0.0009140376350842416
," 0.535262942314148
▁said 0.258320152759552
▁Dr 1.5864217281341553
. 0.5148110389709473
▁Tom 5.213589668273926
▁Brad 6.470804214477539
sh 0.4969559609889984
aw 0.011969509534537792
, 0.04341071844100952
▁CE 0.7832762002944946
O 0.00011087078746641055
▁of 0.03537578508257866
▁British 0.3594326078891754
▁Bi 0.012718028388917446
ote 0.0007597709773108363
ch 0.0015512809623032808
. 0.22338175773620605
▁" 0.2563026249408722
We 0.29305291175842285
’ 2.2979934215545654
re 0.004534795414656401
▁thr 2.326570749282837
illed 1.406679530191468e-05
▁to 0.16532199084758759
▁have 1.1299185752868652
▁the 0.08150780946016312
▁opportunity 0.028179166838526726
▁to 0.0007341814343817532
▁present 0.5275286436080933
▁our 0.49767524003982544
▁find 0.6753671169281006
ings 5.364432126953034e-06
▁at 0.12206878513097763
▁the 0.9538165330886841
▁ES 0.22588001191616058
MO 7.045517122605816e-05
▁conference 0.01505619939416647
▁and 0.4049901068210602
▁look 1.2854557037353516
▁forward 0.00015772631741128862
▁to 0.00012529680680017918
▁discuss 2.0966901779174805
ing 0.0020235376432538033
▁the 0.08831663429737091
▁potential 0.7960848212242126
▁of 0.20481131970882416
▁Mar 0.7724764347076416
im 0.0007837504963390529
ast 6.318291707430035e-05
at 0.000269508920609951
▁with 0.13339079916477203
▁the 0.6189860105514526
▁on 2.1837778091430664
col 0.02362760156393051
ogy 6.6757424974639434e-06
▁community 0.0012697289930656552
." 0.06108690798282623
<0x0A> 0.16848696768283844
Bre 4.0909013748168945
ast 0.025624655187129974
▁cancer 0.17877648770809174
▁is 0.05906905233860016
▁the 0.8961327075958252
▁most 0.062246546149253845
▁common 0.07722947001457214
▁cancer 1.5522868633270264
▁in 0.5292761921882629
▁women 0.038641687482595444
▁world 0.5809364914894104
wide 0.00013411944382824004
, 0.09640450775623322
▁with 0.2191801816225052
▁approximately 2.9814507961273193
▁ 0.0341290682554245
2 0.17163097858428955
. 0.10605113208293915
1 0.6707284450531006
▁million 0.0019846567884087563
▁new 0.06053127348423004
▁cases 0.020303959026932716
▁diagn 0.0548950731754303
osed 0.00012720440281555057
▁each 0.1878686547279358
▁year 5.161895023775287e-05
. 0.037477899342775345
▁While 2.742823362350464
▁traditional 3.168196439743042
▁treat 1.278083324432373
ments 3.695494797284482e-06
▁such 0.530335545539856
▁as 9.871016663964838e-05
▁chem 1.0046319961547852
other 0.00020106667943764478
apy 1.1682578588079195e-05
▁and 0.0797797366976738
▁radiation 0.916629433631897
▁ther 0.7025594115257263
apy 0.0002608043432701379
▁have 0.6790128946304321
▁improved 1.3343936204910278
▁surv 0.2567642033100128
ival 0.00016738384147174656
▁rates 0.0009923730976879597
, 0.19910907745361328
▁they 0.6958902478218079
▁are 2.5413241386413574
▁often 0.5411397218704224
▁associated 0.18020351231098175
▁with 3.349837425048463e-05
▁significant 0.47040098905563354
▁side 0.005305631086230278
▁effects 0.000332410738337785
. 0.9965659379959106
<0x0A> 0.4002664387226105
The 0.7018089890480042
▁potential 1.7675726413726807
▁for 2.9617581367492676
▁a 1.1996657848358154
▁top 0.3519214689731598
ical 0.018432173877954483
▁gel 0.4737634062767029
- 0.03253397345542908
based 0.0002980080316774547
▁treatment 0.048279352486133575
▁like 1.8822085857391357
▁Mar 0.0004432587593328208
im 0.0006982141057960689
ast 9.096082794712856e-05
at 8.905330469133332e-05
▁to 0.4170597195625305
▁offer 3.2107176780700684
▁a 0.766852080821991
▁more 0.8419856429100037
▁target 0.3057122826576233
ed 4.041276770294644e-05
▁and 0.1554846167564392
▁less 0.25652217864990234
▁invas 0.12574750185012817
ive 2.0265599687263602e-06
▁treatment 3.1385083198547363
▁option 0.10366688668727875
▁is 0.9655159711837769
▁a 1.5264314413070679
▁significant 0.580185055732727
▁development 0.7618735432624817
▁in 0.20771214365959167
▁the 0.03926332667469978
▁fight 0.5577922463417053
▁against 8.82187596289441e-05
▁breast 0.04395168274641037
▁cancer 0.0002860836102627218
. 0.015695013105869293
<0x0A> 0.5196452140808105
The 1.4751038551330566
▁review 1.7462891340255737
▁of 0.07678025215864182
▁Mar 0.029878418892621994
im 0.0009219126659445465
ast 0.00010276368993800133
at 0.00015856092795729637
▁at 0.12532013654708862
▁the 0.07276149839162827
▁ES 0.24145320057868958
MO 3.1233324989443645e-05
▁conference 0.003309953259304166
▁will 2.0523648262023926
▁provide 0.7972044348716736
▁an 0.7086213231086731
▁opportunity 0.5536600947380066
▁for 0.25076428055763245
▁health 1.915359616279602
care 0.0022892910055816174
▁profession 0.026710689067840576
als 2.3841860752327193e-07
▁to 0.5272105932235718
▁consider 6.779586315155029
▁the 0.25981777906417847
▁potential 0.3508417308330536
▁benefits 1.710355520248413
▁of 0.0738895907998085
▁the 0.7013554573059082
▁treatment 0.08704822510480881
▁and 0.9368692636489868
▁to 2.205031633377075
▁discuss 0.7951412796974182
▁the 1.0360348224639893
▁next 1.2375235557556152
▁steps 0.003997915890067816
▁in 0.3208041191101074
▁its 0.605703592300415
▁development 0.17495127022266388
. 0.2646573483943939
▁With 3.609618663787842
▁the 1.0936729907989502
▁prospect 5.295681953430176
▁of 0.008864475414156914
▁impro 1.6622309684753418
ving 7.033372639853042e-06
▁surv 0.3944125771522522
ival 0.00022419820015784353
▁rates 0.005421706009656191
▁for 2.6359970569610596
▁breast 0.3867636024951935
▁cancer 5.459934618556872e-05
▁patients 0.0004240577691234648
, 0.22758448123931885
▁the 0.6528252363204956
▁potential 3.1291418075561523
▁of 0.8283965587615967
▁Mar 0.07874739170074463
im 0.0013623572885990143
ast 3.635949542513117e-05
at 0.00010550579463597387
▁is 0.36113059520721436
▁a 1.924209713935852
▁be 8.190059661865234
acon 0.0013301870785653591
▁of 0.0034691595938056707
▁hope 0.0029628612101078033
▁for 0.18695910274982452
▁millions 2.138368606567383
▁of 0.12194191664457321
▁women 0.6861960887908936
▁around 0.34902656078338623
▁the 0.00010836710862349719
▁world 0.011689411476254463
. 0.12582631409168243
